Identification of methylation-regulated genes modulating microglial phagocytosis in hyperhomocysteinemia-exacerbated

Xianwei Wang1, Lu Liu1, Xiaohua Jiang1

  • 1Center for Metabolic Disease Research, Department of Cardiovascular Science, Lewis Kats School of Medicine, Temple University, MERB, Room 1060, 3500 N. Broad Street, Philadelphia, USA.

PubMed
Abstract

Insights

Hyperhomocysteinemia impairs microglial amyloid-beta clearance in Alzheimer's disease. This study identifies key genes involved in this microglial dysfunction, suggesting hypomethylation plays a role.

Area of Science:

  • Neuroscience
  • Genetics
  • Immunology

Background:

  • Hyperhomocysteinemia (HHcy) is linked to Alzheimer's disease (AD) and amyloid-beta (Aβ) accumulation.
  • Microglia (MG) dysfunction exacerbates AD, but HHcy's impact on MG Aβ phagocytosis is unknown.

Approach:

  • Analyzed microglial transcriptomes from HHcy mice (Cbs-/-) and human/mouse AD datasets.
  • Performed meta-analysis integrating MG Aβ phagocytosis models, AD methylomes, and GWAS data.
  • Identified differentially expressed genes (DEGs) and key pathways in HHcy and AD microglia.

Key Points:

  • HHcy and hypomethylation were observed in Cbs-/- mice, with suppressed phagosome and integrin signaling in their microglia.
  • Identified compensatory Aβ phagocytosis activation signatures in human and mouse AD microglia, alongside impaired phagocytosis in human AD microglia.
  • Discovered 5 HHcy-suppressed phagocytic AD MG DEGs (Flt1, Calponin 3, Igf1, Cacna2d4, Celsr) regulating microglial migration and Aβ uptake.

Conclusions:

  • Established molecular signatures for microglial Aβ phagocytosis response in AD.
  • Hypomethylation may modulate HHcy-impaired microglial Aβ phagocytosis in Alzheimer's disease.

Related Concept Videos